AwesomeCapital
Wednesday, August 31, 2022
Hepion starts Phase 2b ‘ASCEND-NASH’ Trial
›
Hepion Pharmaceuticals, Inc. (NASDAQ:HEPA), a clinical stage biopharmaceutical company focused on Artificial Intelligence (“AI”)-driven th...
Signify started at Buy by BTIG
›
Target $35 https://finviz.com/quote.ashx?t=SGFY&ty=c&ta=1&p=d
Bicycle started at Outperform by Cowen
›
Target $30 https://finviz.com/quote.ashx?t=BCYC&ty=c&ta=1&p=d
Longeveron Gets FDA Fast-Track Designation for Lomecel-B in Heart Defect
›
Longeveron Inc. on Wednesday said the U.S. Food and Drug Administration granted fast-track designation to Lomecel-B, the company's lea...
COVID-19 money could run out in January, says US government
›
Access to free COVID-19 test kits is coming to an end in the US this week – but that could also extend to vaccines and drug therapies in t...
Futura eyes FDA filing as topical ED drug passes phase 3 test
›
Futura Medical’s development of a topical treatment for erectile dysfunction (ED) is approaching the finish line in the US, as the UK biot...
Veeva Plummets As A Key Issue Shadows Its Quarterly Beat
›
Medical software maker Veeva Systems ( VEEV ) issued light sales guidance for the current quarter and full year late Wednesday, leadin...
‹
›
Home
View web version